Skip to main content
. 2022 Jan 18;12:747992. doi: 10.3389/fphar.2021.747992

SCHEME 1.

SCHEME 1

Schematic illustration of the preparation of FA-MOF/Buf nanoparticles and the release of active drug (Bufalin, Buf) to tumor sites.